480 related articles for article (PubMed ID: 26391240)
1. Smoking cessation and reduction in people with chronic mental illness.
Tidey JW; Miller ME
BMJ; 2015 Sep; 351():h4065. PubMed ID: 26391240
[TBL] [Abstract][Full Text] [Related]
2. Interventions for smoking cessation and reduction in individuals with schizophrenia.
Tsoi DT; Porwal M; Webster AC
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD007253. PubMed ID: 23450574
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial.
Bullen C; Verbiest M; Galea-Singer S; Kurdziel T; Laking G; Newcombe D; Parag V; Walker N
BMC Public Health; 2018 May; 18(1):596. PubMed ID: 29728074
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for smoking cessation.
Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
[TBL] [Abstract][Full Text] [Related]
5. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
Smith LC; George O
Neuropharmacology; 2020 Nov; 178():108225. PubMed ID: 32758566
[TBL] [Abstract][Full Text] [Related]
6. Interventions to reduce harm from continued tobacco use.
Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
[TBL] [Abstract][Full Text] [Related]
7. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report.
Ziedonis D; Hitsman B; Beckham JC; Zvolensky M; Adler LE; Audrain-McGovern J; Breslau N; Brown RA; George TP; Williams J; Calhoun PS; Riley WT
Nicotine Tob Res; 2008 Dec; 10(12):1691-715. PubMed ID: 19023823
[TBL] [Abstract][Full Text] [Related]
8. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
Roberts E; Eden Evins A; McNeill A; Robson D
Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
Kozak K; George TP
Expert Opin Pharmacother; 2020 Apr; 21(5):581-590. PubMed ID: 32011186
[No Abstract] [Full Text] [Related]
11. Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders.
Das S; Prochaska JJ
Expert Rev Respir Med; 2017 Oct; 11(10):841-850. PubMed ID: 28756728
[TBL] [Abstract][Full Text] [Related]
12. A qualitative study of the views about smoking, licensed cessation aids and e-cigarettes in people with schizophrenia spectrum disorders.
Caponnetto P; Polosa R
J Addict Dis; 2021; 39(2):152-165. PubMed ID: 33043838
[TBL] [Abstract][Full Text] [Related]
13. How do patients and staff in an opioid agonist treatment service view smoking cessation medications and e-cigarettes?
Lobbe C; Bahnisch J; Lin C; Demirkol A; Murnion B
Drug Alcohol Rev; 2023 Jul; 42(5):1092-1103. PubMed ID: 36877583
[TBL] [Abstract][Full Text] [Related]
14. Smoking reduction interventions for smoking cessation.
Lindson N; Klemperer E; Hong B; Ordóñez-Mena JM; Aveyard P
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013183. PubMed ID: 31565800
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Tobacco Smoking: A Review.
Rigotti NA; Kruse GR; Livingstone-Banks J; Hartmann-Boyce J
JAMA; 2022 Feb; 327(6):566-577. PubMed ID: 35133411
[TBL] [Abstract][Full Text] [Related]
16. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.
Peckham E; Brabyn S; Cook L; Tew G; Gilbody S
BMC Psychiatry; 2017 Jul; 17(1):252. PubMed ID: 28705244
[TBL] [Abstract][Full Text] [Related]
18. [Stopping and reducing smoking in patients with schizophrenia].
Underner M; Perriot J; Brousse G; de Chazeron I; Schmitt A; Peiffer G; Harika-Germaneau G; Jaafari N
Encephale; 2019 Sep; 45(4):345-356. PubMed ID: 31153585
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S
Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166
[TBL] [Abstract][Full Text] [Related]
20. Nicotine receptor partial agonists for smoking cessation.
Livingstone-Banks J; Fanshawe TR; Thomas KH; Theodoulou A; Hajizadeh A; Hartman L; Lindson N
Cochrane Database Syst Rev; 2023 May; 5(5):CD006103. PubMed ID: 37142273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
